share_log

Seres Therapeutics | PREM14A: Preliminary proxy statements relating to merger or acquisition

SEC ·  Aug 15, 2024 18:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more